Table of Contents
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
March 15, 2004
GENELABS TECHNOLOGIES, INC.
California | 0-19222 | 94-3010150 | ||
(State of Incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
505 Penobscot Drive, Redwood City, California 94063
(650) 369-9500
ITEM 7. EXHIBITS | ||||||||
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION | ||||||||
SIGNATURE | ||||||||
EXHIBIT INDEX | ||||||||
EXHIBIT 99.1 |
Table of Contents
ITEM 7. EXHIBITS
99.1 | Press Release of Registrant, dated March 15, 2004, entitled “Genelabs Technologies Reports 2003 Year-End and Fourth Quarter Financial Results.” |
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On March 15, 2004, Genelabs Technologies, Inc., a California corporation (“Registrant”), announced its 2003 year-end and fourth quarter financial results. The text of the press release is furnished as Exhibit 99.1 to this Form 8-K.
2
Table of Contents
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized.
GENELABS TECHNOLOGIES, INC. | ||||
By: | /s/ Matthew M. Loar | |||
Name: | Matthew M. Loar | |||
Title: | Chief Financial Officer | |||
Date: March 15, 2004
3